Large-scale testing (Phase 3)Ended earlyNCT01546571What this trial is testingStudy of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma PatientsWho this might be right forMelanoma Polynoma LLC 504
Early research (Phase 1)Study completedNCT01456104What this trial is testingImmune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in MelanomaWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 9
Very early researchStudy completedNCT00580060What this trial is testingInjection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And ImmunityWho this might be right forMelanoma Memorial Sloan Kettering Cancer Center 20
Not applicableUnknownNCT00445783What this trial is testingStudy of Families With MelanomaWho this might be right forMelanoma (Skin) Leeds Cancer Centre at St. James's University Hospital 3,700
Not applicableUnknownNCT00450593What this trial is testingIdentifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaWho this might be right forHereditary Multiple MelanomaMelanoma (Skin) Leeds Cancer Centre at St. James's University Hospital 5,000
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Testing effectiveness (Phase 2)Study completedNCT00003895What this trial is testingVaccine Therapy in Treating HLA-A2 Positive Patients With MelanomaWho this might be right forRecurrent MelanomaStage IA MelanomaStage IB Melanoma+6 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT02129075What this trial is testingA Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV MelanomaWho this might be right forCutaneous MelanomaMelanomaMelanoma of Unknown Primary+9 more National Cancer Institute (NCI) 60
Very early researchStudy completedNCT02320305What this trial is testingMART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryWho this might be right forStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more Mayo Clinic 23
Early research (Phase 1)Not Yet RecruitingNCT07581509What this trial is testingPharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With MelanomaWho this might be right forAdult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings) Biocon Biologics UK PLC 138
Not applicableActive Not RecruitingNCT03677739What this trial is testingYoung Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their FamiliesWho this might be right forClinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+19 more Rutgers, The State University of New Jersey 1,160
Testing effectiveness (Phase 2)Ended earlyNCT01701037What this trial is testingDabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIB Melanoma (Locally Advanced)Stage IIC Melanoma (Locally Advanced)+4 more Vanderbilt-Ingram Cancer Center 13
Not applicableNot Yet RecruitingNCT06780397What this trial is testingClinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma PatientsWho this might be right forMelanoma, Stage IIMelanoma Stage IIIMelanoma Stage IV Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT01460875What this trial is testingRecombinant Interferon Alfa-2b in Treating Patients With MelanomaWho this might be right forStage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more William Carson 34
Early research (Phase 1)Study completedNCT00515983What this trial is testingVaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma CellsWho this might be right forMelanoma José Mordoh, M.D., Ph.D. 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291What this trial is testingA Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With SurgeryWho this might be right forMelanoma Regeneron Pharmaceuticals 1,564
Early research (Phase 1)Study completedNCT02696356What this trial is testingPhase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected MelanomaWho this might be right forMelanoma BrightPath Biotherapeutics 18
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00089193What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Craig L Slingluff, Jr